Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

    Cantor LB, Hoop J, Morgan L, Wudunn D, Catoira Y; Bimatoprost-Travoprost Study Group.

    Br J Ophthalmol. 2006 Nov;90(11):1370-3. Epub 2006 Jul 6.PMID: 16825272 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

    Cantor LB, WuDunn D, Cortes A, Hoop J, Knotts S.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S12-8.PMID: 15016557 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparing bimatoprost and travoprost in black Americans.

    Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP.

    Curr Med Res Opin. 2006 Nov;22(11):2175-80.PMID: 17076978 [PubMed - indexed for MEDLINE]Related articles

    4.

    A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

    Parrish RK, Palmberg P, Sheu WP; XLT Study Group.

    Am J Ophthalmol. 2003 May;135(5):688-703.PMID: 12719078 [PubMed - indexed for MEDLINE]Related articles

    5.

    Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension.

    Noecker RJ, Earl ML, Mundorf T, Peace J, Williams RD.

    Adv Ther. 2003 Mar-Apr;20(2):121-8.PMID: 12836812 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.

    Frenkel RE, Noecker RJ, Craven ER.

    Curr Med Res Opin. 2008 Apr;24(4):919-23. Epub 2008 Feb 8.PMID: 18267054 [PubMed - indexed for MEDLINE]Related articles

    7.

    A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

    Am J Ophthalmol. 2003 Jan;135(1):55-63.PMID: 12504698 [PubMed - indexed for MEDLINE]Related articles

    8.

    24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.

    Hepsen IF, Ozkaya E.

    Eye (Lond). 2007 Apr;21(4):453-8. Epub 2006 Mar 17.PMID: 16543930 [PubMed - indexed for MEDLINE]Related articles

    9.

    Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.

    Gagliuso DJ, Wang RF, Mittag TW, Podos SM.

    Arch Ophthalmol. 2004 Sep;122(9):1342-7.PMID: 15364714 [PubMed - indexed for MEDLINE]Related articles

    10.

    A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

    Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD.

    Adv Ther. 2006 May-Jun;23(3):385-94.PMID: 16912020 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.

    Varma R, Hwang LJ, Grunden JW, Bean GW.

    Am J Ophthalmol. 2008 Feb;145(2):336-42.PMID: 18222194 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.

    Yildirim N, Sahin A, Gultekin S.

    J Glaucoma. 2008 Jan-Feb;17(1):36-9.PMID: 18303382 [PubMed - indexed for MEDLINE]Related articles

    13.

    Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

    Easthope SE, Perry CM.

    Drugs Aging. 2002;19(3):231-48. Review.PMID: 12027782 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

    Aptel F, Cucherat M, Denis P.

    J Glaucoma. 2008 Dec;17(8):667-73.PMID: 19092464 [PubMed - indexed for MEDLINE]Related articles

    15.

    24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.PMID: 15016559 [PubMed - indexed for MEDLINE]Related articles

    16.
    18.

    Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.

    Cellini M, Caramazza R, Bonsanto D, Bernabini B, Campos EC.

    Ophthalmologica. 2004 Sep-Oct;218(5):312-7.PMID: 15334011 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

    Koz OG, Ozsoy A, Yarangumeli A, Kose SK, Kural G.

    Acta Ophthalmol Scand. 2007 Dec;85(8):838-43. Epub 2007 Aug 2.PMID: 17680841 [PubMed - indexed for MEDLINE]Related articles

    20.

    Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

    Li N, Chen XM, Zhou Y, Wei ML, Yao X.

    Clin Experiment Ophthalmol. 2006 Nov;34(8):755-64.PMID: 17073898 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data